Echocardiographic assessment of the right ventricle in COVID-19: a systematic review.
Int J Cardiovasc Imaging
; 37(12): 3499-3512, 2021 Dec.
Article
in English
| MEDLINE | ID: covidwho-1525551
ABSTRACT
Cardiac involvement has been frequently reported in COVID-19 as responsible of increased morbidity and mortality. Given the importance of right heart function in acute and chronic respiratory diseases, its assessment in SARS-CoV-2 infected patients may add prognostic accuracy. Transthoracic echocardiography has been proposed to early predict myocardial injury and risk of death in hospitalized patients. This systematic review presents the up-to-date sum of literature regarding right ventricle ultrasound assessment. We evaluated commonly used echocardiographic parameters to assess RV function and discussed their relationship with pathophysiological mechanisms involved in COVID-19. We searched Medline and Embase for studies that used transthoracic echocardiography for right ventricle assessment in patients with COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Ventricular Dysfunction, Right
/
COVID-19
Type of study:
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
/
Reviews
/
Systematic review/Meta Analysis
Limits:
Humans
Language:
English
Journal:
Int J Cardiovasc Imaging
Journal subject:
Diagnostic Imaging
Year:
2021
Document Type:
Article
Affiliation country:
S10554-021-02353-6
Similar
MEDLINE
...
LILACS
LIS